REVIEW
Accepted on 19 Sep 2025
Targeting ferroptosis, pyroptosis and necroptosis for cancer immunotherapy in melanoma: mechanistic insights and clinical perspectives
doi 10.3389/fimmu.2025.1629620
- 687 views
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Current Insights in Melanoma Immunology, Immune Escape and Immunotherapy Advances
Current Insights in Melanoma Immunology, Immune Escape and Immunotherapy Advances
7,908
Total downloads
34k
Total views and downloads
Articles
ORIGINAL RESEARCH
Published on 20 Aug 2025
Programmed cell death-driven remodeling of the melanoma microenvironment enables prognostic stratification and therapeutic prediction
doi 10.3389/fimmu.2025.1612217
- 2,188 views
ORIGINAL RESEARCH
Published on 01 Aug 2025
Baseline metabolic signatures predict clinical outcomes in immunotherapy-treated melanoma patients: a pilot study
doi 10.3389/fimmu.2025.1536710
- 1,419 views
PERSPECTIVE
Published on 01 Jul 2025
CTLA-4 and PD-1 combined blockade therapy for malignant melanoma brain metastases: mechanisms, challenges, and prospects
doi 10.3389/fimmu.2025.1629879
- 2,491 views
- 1 citation
ORIGINAL RESEARCH
Published on 20 Jun 2025
Overexpression of CTLA-4 and fibronectin, and lower expression of CD137 (4-1BB) is associated with brain metastasis of primary skin melanomas. An analysis of local immune response by digital spatial profiling
doi 10.3389/fimmu.2025.1578986
- 1,220 views
ORIGINAL RESEARCH
Published on 18 Jun 2025
Identification and validation of a KRAS-macrophage-associated gene signature as prognostic biomarkers and potential therapeutic targets in melanoma
doi 10.3389/fimmu.2025.1566432
- 2,088 views
REVIEW
Published on 08 May 2025
Management of immune-related myocarditis, myositis and myasthenia gravis (MMM) overlap syndrome: a single institution case series and literature review
doi 10.3389/fimmu.2025.1597259
- 5,132 views
- 7 citations
ORIGINAL RESEARCH
Published on 08 May 2025
Translating genetics into tissue: inflammatory cytokine-producing TAMs and PD-L1 tumor expression as poor prognosis factors in cutaneous melanoma
doi 10.3389/fimmu.2025.1587545
- 1,516 views
- 1 citation
CASE REPORT
Published on 10 Apr 2025
Case Report: Durable remission after abscopal effect following transcatheter hepatic arterial embolization in a patient with mucosal melanoma refractory to immunotherapy
doi 10.3389/fimmu.2025.1565355
- 1,515 views
ORIGINAL RESEARCH
Published on 03 Apr 2025
Exhaled breath analysis with the use of an electronic nose to predict response to immune checkpoint inhibitors in patients with metastatic melanoma: melaNose trial
doi 10.3389/fimmu.2025.1564463
- 2,061 views
ORIGINAL RESEARCH
Published on 28 Mar 2025
Transcriptomic signatures in peripheral CD4+T-lymphocytes may reflect melanoma staging and immunotherapy responsiveness prior to ICI initiation
doi 10.3389/fimmu.2025.1529707
- 3,386 views
ORIGINAL RESEARCH
Published on 16 Dec 2024
Impact of steroid-sparing immunosuppressive agents on tumor outcome in the context of cancer immunotherapy with highlight on melanoma: a systematic literature review and meta-analysis
doi 10.3389/fimmu.2024.1499478
- 2,540 views
- 2 citations
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.3 impact factor
- 6.9 citescore